235 related articles for article (PubMed ID: 29172719)
21. Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study.
Zhao J; Guo XJ; Shi L
Curr Med Res Opin; 2024 Jan; 40(1):113-122. PubMed ID: 37938089
[TBL] [Abstract][Full Text] [Related]
22. Engagement of T-cell antigen receptor and CD4/CD8 co-receptors induces prolonged STAT activation through autocrine/paracrine stimulation in human primary T cells.
Chueh FY; Yu CL
Biochem Biophys Res Commun; 2012 Sep; 426(2):242-6. PubMed ID: 22935418
[TBL] [Abstract][Full Text] [Related]
23. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia.
Kourakata H; Takada T; Suzuki E; Enomoto K; Saito I; Taguchi Y; Tsukada H; Nakano M; Arakawa M
Respirology; 1999 Sep; 4(3):223-8. PubMed ID: 10489663
[TBL] [Abstract][Full Text] [Related]
24. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients.
Benveniste O; Chérin P; Maisonobe T; Merat R; Chosidow O; Mouthon L; Guillevin L; Flahault A; Burland MC; Klatzmann D; Herson S; Boyer O
J Immunol; 2001 Sep; 167(6):3521-9. PubMed ID: 11544346
[TBL] [Abstract][Full Text] [Related]
25. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
[TBL] [Abstract][Full Text] [Related]
26. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
Peng QL; Shu XM; Tian XL; Lu X; Wang GC
Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773
[TBL] [Abstract][Full Text] [Related]
27. A Study Based on the Correlation Between Slit2/Robo1 Signaling Pathway Proteins and Polymyositis/Dermatomyositis.
Chai KX; Chen YQ; Kong LS; Fan PL; Yuan X; Yang J
Curr Mol Med; 2020; 20(9):717-722. PubMed ID: 32213157
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
Jiang Q; Li Y; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
[TBL] [Abstract][Full Text] [Related]
30. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis.
Sugiura T; Harigai M; Kawaguchi Y; Takagi K; Fukasawa C; Ohsako-Higami S; Ohta S; Tanaka M; Hara M; Kamatani N
Int Immunol; 2002 Aug; 14(8):917-24. PubMed ID: 12147628
[TBL] [Abstract][Full Text] [Related]
31. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
32. [Recent research developments in polymyositis/dermatomyositis].
Okiyama N; Kohsaka H
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Apr; 31(2):85-92. PubMed ID: 18446010
[TBL] [Abstract][Full Text] [Related]
33. B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis.
Peng QL; Shu XM; Wang DX; Wang Y; Lu X; Wang GC
Biomark Med; 2014; 8(3):395-403. PubMed ID: 24712431
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
35. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.
Sugiura T; Murakawa Y; Nagai A; Kondo M; Kobayashi S
Arthritis Rheum; 1999 Feb; 42(2):291-8. PubMed ID: 10025923
[TBL] [Abstract][Full Text] [Related]
36. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
[TBL] [Abstract][Full Text] [Related]
37. The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis.
Zhang L; Xia Q; Li W; Peng Q; Yang H; Lu X; Wang G
Arthritis Res Ther; 2019 May; 21(1):131. PubMed ID: 31142372
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
39. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
[TBL] [Abstract][Full Text] [Related]
40. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
